Dingxi Liu, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Peer review Peer review information Nature Metabolism thanks Timo Mller and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
The FDA's Pharmacy Compounding Advisory Committee (PCAC) is scheduled to review TB-500 in July 2026 for possible placement on the 503A Bulks List (Category 1)
After this assessment, the doctor will decide if tesofensine is right for you and your health goals
Meto's Perspective: What We Think Patients Deserve to Know At Meto, our clinical focus is on metabolic and hormonal health the kind of deep, root-cause medicine that requires real diagnostics, physician oversight, and evidence-based treatment protocols
If your COA indicates a different content, your concentration changes
